BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2440389)

  • 1. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
    Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
    Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced cervical cancer by a combination of peplomycin, vincristine, mitomycin-C, and cisplatin.
    Sugimori H; Iwasaka T; Fukuda K; Hayashi Y; Hachisuga T
    Gynecol Oncol; 1989 Aug; 34(2):180-2. PubMed ID: 2473949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
    Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D
    Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
    Wheelock JB; Krebs HB; Goplerud DR
    Gynecol Oncol; 1990 Apr; 37(1):21-3. PubMed ID: 1691126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
    Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
    Chambers SK; Flynn SD; Del Prete SA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1989 Mar; 32(3):303-9. PubMed ID: 2465939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
    Belinson JL; Stewart JA; Richards AL; McClure M
    Gynecol Oncol; 1985 Mar; 20(3):387-93. PubMed ID: 2579010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
    Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
    Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the uterine cervix.
    Chander S; Ghosh D; Aggarwal N
    Indian J Cancer; 1986 Mar; 23(1):43-8. PubMed ID: 2434412
    [No Abstract]   [Full Text] [Related]  

  • 11. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
    Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
    Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
    Lele SB; Piver MS
    Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of a patient with FIGO stage IV vulvar cancer with bleomycin, vincristine, mitomycin C, and cisplatin].
    Shimizu Y; Hasumi K; Yagi H; Nakayama K; Chen JT; Hirai Y; Hamada T; Fujimoto I; Yamauchi K; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):609-12. PubMed ID: 2474044
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant combination chemotherapy in the treatment of advanced cancer of the uterine cervix.
    Chander S; Ghosh D; Aggarwal N
    Indian J Cancer; 1985 Dec; 22(4):266-70. PubMed ID: 2435654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant chemotherapy in radical surgery of cervix cancer].
    Lahousen M; Haas H; Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():372-4. PubMed ID: 2482234
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
    Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
    J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH; Baker SR; Liepman MK; Ensminger WD
    Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.